Department of Oral Biological and Medical Sciences, The University of British Columbia, Vancouver, BC, Canada.
BC Oral Cancer Prevention Program, Cancer Control Research, British Columbia Cancer Research Centre, Vancouver, BC, Canada.
Can J Dent Hyg. 2021 Feb 15;55(1):9-16. eCollection 2021 Feb.
Two subtypes of lichenoid mucositis (LM) with oral epithelial dysplasia have been proposed, with differing risks of malignant transformation. However, no research has been done to authenticate this hypothesis. The study objective was to determine whether there are 2 subcategories within this entity, one with primary lichenoid and secondary dysplastic features (LD), and the other with primary dysplastic and secondary lichenoid features (DL), and to compare the proportion of malignant progression in these groups.
Patients with a diagnosis of lichenoid mucositis with low-grade (mild/moderate) oral epithelial dysplasia, no history of head and neck cancer, and who had at least 5 years of follow-up were eligible to participate in this nested case-control study. Cases (n = 10) were defined as lesions that progressed to severe dysplasia, carcinoma in situ or squamous cell carcinoma; controls (n = 32) were defined as those that did not progress. Immunohistochemistry was performed to assess for basement membrane (BM) degeneration using collagen IV-an integral BM protein.
Lesions that progressed to cancer exhibited a similar proportion of BM degeneration at baseline (70%) compared to non-progressors (78%), with no statistically significant difference between groups ( = 0.69).
BM degeneration is frequently seen in LM with dysplasia and alone does not appear to be a predictor of malignant progression in lesions with both lichenoid and low-grade dysplastic features. Dysplasia should not be discounted in the presence of LM. Lesions that display any degree of dysplasia warrant clinical follow-up and continued monitoring.
两种伴有口腔上皮异型增生的苔藓样黏膜炎(lichenoid mucositis,LM)亚型已经被提出,它们具有不同的恶变风险。然而,目前还没有研究来验证这一假说。本研究旨在确定这种情况下是否存在两个亚类,一个是原发性苔藓样和继发性异型增生(lichenoid dysplasia,LD)特征,另一个是原发性异型增生和继发性苔藓样特征(dysplastic lichenoid,DL),并比较这些组中恶性进展的比例。
患有低度(轻度/中度)口腔上皮异型增生的苔藓样黏膜炎,并具有以下特征的患者有资格参加这项巢式病例对照研究:无头颈部癌症病史,且至少有 5 年的随访。病例(n=10)定义为病变进展为重度异型增生、原位癌或鳞状细胞癌;对照组(n=32)定义为未进展的病变。使用胶原蛋白 IV (一种完整的基底膜蛋白)进行免疫组织化学染色来评估基底膜(basement membrane,BM)退变。
进展为癌症的病变在基线时(70%)与非进展病变(78%)相比,BM 退变的比例相似,两组之间无统计学差异(=0.69)。
BM 退变在伴有异型增生的 LM 中经常出现,而且单独来看,它似乎不是具有苔藓样和低度异型增生特征的病变恶性进展的预测因素。在存在 LM 的情况下,不应忽视异型增生。显示任何程度异型增生的病变都需要进行临床随访和持续监测。